Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regul...
News from Biomedical Diagnostic Center
Clínic-IDIBAPS and EF CLIF Foundation renew the agreement to boost research on chronic liver diseases
Hospital Clínic Barcelona-IDIBAPS and the European Foundation for the Study of Chronic Liver Failure (EF CLIF) have renewed their framework collabo...
Neonatal Detection of Sickle Cell Disease in Catalonia Reduces Complications in Paediatric Patients
A study jointly led by the Hospital Clínic-IDIBAPS and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening...
5 tips for safe wild mushroom foraging
With the arrival of the mushroom season, many enthusiasts take to the woods to hunt for them. However, it is essential to follow certain guidelines...
Green light for ARI0002h CAR-T developed by Clínic-IDIBAPS for patients with multiple myeloma
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved AR...
The Clínic includes a blood test as part of the Alzheimer’s diagnostic process to identify the disease
The centre becomes the first in Spain to use blood biomarker p-tau217, which offers a more accurate and less invasive diagnosis and marks a paradig...
Premiere of the documentary 'ARI, a story of love and life', about how the CAR-T became a reality at the Clínic
The Hospital Clínic Barcelona has presented the documentary ARI. "A story of love and lif", which tells the story of Ariana Benedé, Ari, and how a...
Neonatal screening: Why it is so beneficial for newborns
Neonatal screening programmes are used to detect serious congenital diseases so they can be treated early and thus prevent significant sequelae.
The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personal...
The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients...